nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—P-Glycoprotein Inhibitors—Crizotinib—lung cancer	0.539	1	CiPCiCtD
Ticagrelor—ABCB1—lung cancer	0.133	1	CbGaD
Ticagrelor—ABCB1—Topotecan—lung cancer	0.0191	0.0864	CbGbCtD
Ticagrelor—ABCB1—Gefitinib—lung cancer	0.0175	0.079	CbGbCtD
Ticagrelor—ABCB1—Vinorelbine—lung cancer	0.0134	0.0609	CbGbCtD
Ticagrelor—CYP3A4—Topotecan—lung cancer	0.0114	0.0518	CbGbCtD
Ticagrelor—ABCB1—Crizotinib—lung cancer	0.0107	0.0484	CbGbCtD
Ticagrelor—CYP3A4—Gefitinib—lung cancer	0.0105	0.0473	CbGbCtD
Ticagrelor—ABCB1—Gemcitabine—lung cancer	0.0105	0.0473	CbGbCtD
Ticagrelor—ABCB1—Erlotinib—lung cancer	0.0103	0.0467	CbGbCtD
Ticagrelor—CYP3A4—Teniposide—lung cancer	0.0101	0.0459	CbGbCtD
Ticagrelor—ABCB1—Paclitaxel—lung cancer	0.00945	0.0428	CbGbCtD
Ticagrelor—ABCB1—Irinotecan—lung cancer	0.00932	0.0422	CbGbCtD
Ticagrelor—ABCB1—Vinblastine—lung cancer	0.00829	0.0375	CbGbCtD
Ticagrelor—CYP3A4—Vinorelbine—lung cancer	0.00806	0.0365	CbGbCtD
Ticagrelor—ABCB1—Cisplatin—lung cancer	0.0076	0.0344	CbGbCtD
Ticagrelor—ABCB1—Etoposide—lung cancer	0.00746	0.0338	CbGbCtD
Ticagrelor—ABCB1—Docetaxel—lung cancer	0.00683	0.0309	CbGbCtD
Ticagrelor—CYP3A4—Crizotinib—lung cancer	0.00641	0.029	CbGbCtD
Ticagrelor—CYP3A4—Erlotinib—lung cancer	0.00618	0.028	CbGbCtD
Ticagrelor—CYP3A4—Paclitaxel—lung cancer	0.00566	0.0256	CbGbCtD
Ticagrelor—CYP3A4—Irinotecan—lung cancer	0.00558	0.0253	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—lung cancer	0.00509	0.023	CbGbCtD
Ticagrelor—CYP3A4—Vinblastine—lung cancer	0.00496	0.0225	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—lung cancer	0.00493	0.0223	CbGbCtD
Ticagrelor—CYP3A4—Etoposide—lung cancer	0.00447	0.0202	CbGbCtD
Ticagrelor—CYP3A4—Docetaxel—lung cancer	0.00409	0.0185	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—lung cancer	0.00305	0.0138	CbGbCtD
Ticagrelor—Nervous system disorder—Cisplatin—lung cancer	6.79e-05	0.000834	CcSEcCtD
Ticagrelor—Cough—Etoposide—lung cancer	6.78e-05	0.000833	CcSEcCtD
Ticagrelor—Headache—Topotecan—lung cancer	6.77e-05	0.000832	CcSEcCtD
Ticagrelor—Rash—Erlotinib—lung cancer	6.74e-05	0.000828	CcSEcCtD
Ticagrelor—Dermatitis—Erlotinib—lung cancer	6.74e-05	0.000827	CcSEcCtD
Ticagrelor—Angiopathy—Docetaxel—lung cancer	6.73e-05	0.000827	CcSEcCtD
Ticagrelor—Skin disorder—Cisplatin—lung cancer	6.73e-05	0.000826	CcSEcCtD
Ticagrelor—Dyspepsia—Irinotecan—lung cancer	6.71e-05	0.000825	CcSEcCtD
Ticagrelor—Hypertension—Etoposide—lung cancer	6.71e-05	0.000824	CcSEcCtD
Ticagrelor—Immune system disorder—Docetaxel—lung cancer	6.7e-05	0.000823	CcSEcCtD
Ticagrelor—Headache—Erlotinib—lung cancer	6.7e-05	0.000823	CcSEcCtD
Ticagrelor—Loss of consciousness—Paclitaxel—lung cancer	6.7e-05	0.000823	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	6.7e-05	0.000822	CcSEcCtD
Ticagrelor—Mediastinal disorder—Docetaxel—lung cancer	6.69e-05	0.000821	CcSEcCtD
Ticagrelor—Paraesthesia—Gemcitabine—lung cancer	6.67e-05	0.000819	CcSEcCtD
Ticagrelor—Cough—Paclitaxel—lung cancer	6.65e-05	0.000817	CcSEcCtD
Ticagrelor—Asthenia—Vinorelbine—lung cancer	6.64e-05	0.000815	CcSEcCtD
Ticagrelor—Dyspnoea—Gemcitabine—lung cancer	6.62e-05	0.000813	CcSEcCtD
Ticagrelor—Chest pain—Etoposide—lung cancer	6.62e-05	0.000813	CcSEcCtD
Ticagrelor—Nausea—Vinblastine—lung cancer	6.61e-05	0.000812	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Irinotecan—lung cancer	6.59e-05	0.000809	CcSEcCtD
Ticagrelor—Hypertension—Paclitaxel—lung cancer	6.58e-05	0.000808	CcSEcCtD
Ticagrelor—Fatigue—Irinotecan—lung cancer	6.58e-05	0.000808	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	6.57e-05	0.000807	CcSEcCtD
Ticagrelor—Pruritus—Vinorelbine—lung cancer	6.54e-05	0.000804	CcSEcCtD
Ticagrelor—Constipation—Irinotecan—lung cancer	6.52e-05	0.000801	CcSEcCtD
Ticagrelor—Mental disorder—Docetaxel—lung cancer	6.5e-05	0.000798	CcSEcCtD
Ticagrelor—Chest pain—Paclitaxel—lung cancer	6.49e-05	0.000797	CcSEcCtD
Ticagrelor—Hypotension—Cisplatin—lung cancer	6.47e-05	0.000795	CcSEcCtD
Ticagrelor—Malnutrition—Docetaxel—lung cancer	6.46e-05	0.000793	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	6.44e-05	0.000791	CcSEcCtD
Ticagrelor—Nausea—Topotecan—lung cancer	6.42e-05	0.000789	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Gemcitabine—lung cancer	6.41e-05	0.000788	CcSEcCtD
Ticagrelor—Fatigue—Gemcitabine—lung cancer	6.41e-05	0.000787	CcSEcCtD
Ticagrelor—Confusional state—Etoposide—lung cancer	6.4e-05	0.000786	CcSEcCtD
Ticagrelor—Constipation—Gemcitabine—lung cancer	6.35e-05	0.00078	CcSEcCtD
Ticagrelor—Nausea—Erlotinib—lung cancer	6.35e-05	0.00078	CcSEcCtD
Ticagrelor—Diarrhoea—Vinorelbine—lung cancer	6.33e-05	0.000777	CcSEcCtD
Ticagrelor—Feeling abnormal—Irinotecan—lung cancer	6.29e-05	0.000772	CcSEcCtD
Ticagrelor—Confusional state—Paclitaxel—lung cancer	6.27e-05	0.00077	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—lung cancer	6.27e-05	0.00077	CcSEcCtD
Ticagrelor—Back pain—Docetaxel—lung cancer	6.25e-05	0.000767	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Irinotecan—lung cancer	6.24e-05	0.000766	CcSEcCtD
Ticagrelor—Paraesthesia—Cisplatin—lung cancer	6.22e-05	0.000764	CcSEcCtD
Ticagrelor—Dyspnoea—Cisplatin—lung cancer	6.17e-05	0.000758	CcSEcCtD
Ticagrelor—Skin disorder—Etoposide—lung cancer	6.16e-05	0.000757	CcSEcCtD
Ticagrelor—Feeling abnormal—Gemcitabine—lung cancer	6.12e-05	0.000752	CcSEcCtD
Ticagrelor—Shock—Paclitaxel—lung cancer	6.12e-05	0.000752	CcSEcCtD
Ticagrelor—Dizziness—Vinorelbine—lung cancer	6.12e-05	0.000751	CcSEcCtD
Ticagrelor—Nervous system disorder—Paclitaxel—lung cancer	6.1e-05	0.000749	CcSEcCtD
Ticagrelor—Breast disorder—Doxorubicin—lung cancer	6.05e-05	0.000743	CcSEcCtD
Ticagrelor—Skin disorder—Paclitaxel—lung cancer	6.04e-05	0.000742	CcSEcCtD
Ticagrelor—Abdominal pain—Irinotecan—lung cancer	6.03e-05	0.00074	CcSEcCtD
Ticagrelor—Body temperature increased—Irinotecan—lung cancer	6.03e-05	0.00074	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Cisplatin—lung cancer	5.98e-05	0.000734	CcSEcCtD
Ticagrelor—Hypotension—Etoposide—lung cancer	5.93e-05	0.000728	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—lung cancer	5.93e-05	0.000728	CcSEcCtD
Ticagrelor—Vomiting—Vinorelbine—lung cancer	5.88e-05	0.000722	CcSEcCtD
Ticagrelor—Body temperature increased—Gemcitabine—lung cancer	5.87e-05	0.000721	CcSEcCtD
Ticagrelor—Rash—Vinorelbine—lung cancer	5.83e-05	0.000716	CcSEcCtD
Ticagrelor—Dermatitis—Vinorelbine—lung cancer	5.83e-05	0.000715	CcSEcCtD
Ticagrelor—Hypotension—Paclitaxel—lung cancer	5.81e-05	0.000714	CcSEcCtD
Ticagrelor—Headache—Vinorelbine—lung cancer	5.79e-05	0.000712	CcSEcCtD
Ticagrelor—Syncope—Docetaxel—lung cancer	5.79e-05	0.000712	CcSEcCtD
Ticagrelor—Feeling abnormal—Cisplatin—lung cancer	5.71e-05	0.000701	CcSEcCtD
Ticagrelor—Paraesthesia—Etoposide—lung cancer	5.7e-05	0.0007	CcSEcCtD
Ticagrelor—Haematuria—Methotrexate—lung cancer	5.68e-05	0.000698	CcSEcCtD
Ticagrelor—Loss of consciousness—Docetaxel—lung cancer	5.68e-05	0.000697	CcSEcCtD
Ticagrelor—Dyspnoea—Etoposide—lung cancer	5.66e-05	0.000695	CcSEcCtD
Ticagrelor—Cough—Docetaxel—lung cancer	5.64e-05	0.000692	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—lung cancer	5.62e-05	0.00069	CcSEcCtD
Ticagrelor—Hypersensitivity—Irinotecan—lung cancer	5.62e-05	0.00069	CcSEcCtD
Ticagrelor—Paraesthesia—Paclitaxel—lung cancer	5.59e-05	0.000686	CcSEcCtD
Ticagrelor—Hypertension—Docetaxel—lung cancer	5.58e-05	0.000685	CcSEcCtD
Ticagrelor—Dyspnoea—Paclitaxel—lung cancer	5.55e-05	0.000681	CcSEcCtD
Ticagrelor—Chest pain—Docetaxel—lung cancer	5.5e-05	0.000675	CcSEcCtD
Ticagrelor—Nausea—Vinorelbine—lung cancer	5.49e-05	0.000675	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Etoposide—lung cancer	5.48e-05	0.000673	CcSEcCtD
Ticagrelor—Dyspepsia—Paclitaxel—lung cancer	5.48e-05	0.000672	CcSEcCtD
Ticagrelor—Body temperature increased—Cisplatin—lung cancer	5.47e-05	0.000672	CcSEcCtD
Ticagrelor—Asthenia—Irinotecan—lung cancer	5.47e-05	0.000672	CcSEcCtD
Ticagrelor—Fatigue—Etoposide—lung cancer	5.47e-05	0.000672	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	5.46e-05	0.000671	CcSEcCtD
Ticagrelor—Constipation—Etoposide—lung cancer	5.43e-05	0.000666	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—lung cancer	5.38e-05	0.00066	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Paclitaxel—lung cancer	5.37e-05	0.00066	CcSEcCtD
Ticagrelor—Fatigue—Paclitaxel—lung cancer	5.36e-05	0.000659	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—lung cancer	5.35e-05	0.000657	CcSEcCtD
Ticagrelor—Asthenia—Gemcitabine—lung cancer	5.33e-05	0.000655	CcSEcCtD
Ticagrelor—Constipation—Paclitaxel—lung cancer	5.32e-05	0.000653	CcSEcCtD
Ticagrelor—Confusional state—Docetaxel—lung cancer	5.32e-05	0.000653	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—lung cancer	5.28e-05	0.000649	CcSEcCtD
Ticagrelor—Pruritus—Gemcitabine—lung cancer	5.26e-05	0.000646	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—lung cancer	5.24e-05	0.000644	CcSEcCtD
Ticagrelor—Feeling abnormal—Etoposide—lung cancer	5.23e-05	0.000642	CcSEcCtD
Ticagrelor—Diarrhoea—Irinotecan—lung cancer	5.22e-05	0.000641	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Etoposide—lung cancer	5.19e-05	0.000637	CcSEcCtD
Ticagrelor—Shock—Docetaxel—lung cancer	5.19e-05	0.000637	CcSEcCtD
Ticagrelor—Nervous system disorder—Docetaxel—lung cancer	5.17e-05	0.000635	CcSEcCtD
Ticagrelor—Feeling abnormal—Paclitaxel—lung cancer	5.13e-05	0.00063	CcSEcCtD
Ticagrelor—Skin disorder—Docetaxel—lung cancer	5.12e-05	0.000629	CcSEcCtD
Ticagrelor—Hypersensitivity—Cisplatin—lung cancer	5.1e-05	0.000627	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Paclitaxel—lung cancer	5.09e-05	0.000625	CcSEcCtD
Ticagrelor—Diarrhoea—Gemcitabine—lung cancer	5.08e-05	0.000624	CcSEcCtD
Ticagrelor—Dizziness—Irinotecan—lung cancer	5.04e-05	0.000619	CcSEcCtD
Ticagrelor—Abdominal pain—Etoposide—lung cancer	5.02e-05	0.000616	CcSEcCtD
Ticagrelor—Body temperature increased—Etoposide—lung cancer	5.02e-05	0.000616	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—lung cancer	5e-05	0.000614	CcSEcCtD
Ticagrelor—Asthenia—Cisplatin—lung cancer	4.97e-05	0.00061	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—lung cancer	4.96e-05	0.00061	CcSEcCtD
Ticagrelor—Hypotension—Docetaxel—lung cancer	4.93e-05	0.000605	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—lung cancer	4.92e-05	0.000604	CcSEcCtD
Ticagrelor—Abdominal pain—Paclitaxel—lung cancer	4.92e-05	0.000604	CcSEcCtD
Ticagrelor—Body temperature increased—Paclitaxel—lung cancer	4.92e-05	0.000604	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—lung cancer	4.87e-05	0.000598	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—lung cancer	4.85e-05	0.000596	CcSEcCtD
Ticagrelor—Vomiting—Irinotecan—lung cancer	4.85e-05	0.000596	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—lung cancer	4.83e-05	0.000593	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—lung cancer	4.82e-05	0.000592	CcSEcCtD
Ticagrelor—Rash—Irinotecan—lung cancer	4.81e-05	0.000591	CcSEcCtD
Ticagrelor—Dermatitis—Irinotecan—lung cancer	4.8e-05	0.00059	CcSEcCtD
Ticagrelor—Headache—Irinotecan—lung cancer	4.78e-05	0.000587	CcSEcCtD
Ticagrelor—Diarrhoea—Cisplatin—lung cancer	4.74e-05	0.000582	CcSEcCtD
Ticagrelor—Paraesthesia—Docetaxel—lung cancer	4.73e-05	0.000581	CcSEcCtD
Ticagrelor—Vomiting—Gemcitabine—lung cancer	4.72e-05	0.00058	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—lung cancer	4.72e-05	0.000579	CcSEcCtD
Ticagrelor—Dyspnoea—Docetaxel—lung cancer	4.7e-05	0.000577	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—lung cancer	4.69e-05	0.000576	CcSEcCtD
Ticagrelor—Rash—Gemcitabine—lung cancer	4.68e-05	0.000575	CcSEcCtD
Ticagrelor—Dermatitis—Gemcitabine—lung cancer	4.68e-05	0.000575	CcSEcCtD
Ticagrelor—Hypersensitivity—Etoposide—lung cancer	4.67e-05	0.000574	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—lung cancer	4.66e-05	0.000572	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—lung cancer	4.66e-05	0.000572	CcSEcCtD
Ticagrelor—Headache—Gemcitabine—lung cancer	4.65e-05	0.000572	CcSEcCtD
Ticagrelor—Dyspepsia—Docetaxel—lung cancer	4.64e-05	0.00057	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—lung cancer	4.63e-05	0.000569	CcSEcCtD
Ticagrelor—Hypersensitivity—Paclitaxel—lung cancer	4.58e-05	0.000563	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—lung cancer	4.57e-05	0.000562	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—lung cancer	4.56e-05	0.00056	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Docetaxel—lung cancer	4.55e-05	0.000559	CcSEcCtD
Ticagrelor—Asthenia—Etoposide—lung cancer	4.55e-05	0.000559	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—lung cancer	4.55e-05	0.000559	CcSEcCtD
Ticagrelor—Fatigue—Docetaxel—lung cancer	4.55e-05	0.000558	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—lung cancer	4.54e-05	0.000558	CcSEcCtD
Ticagrelor—Nausea—Irinotecan—lung cancer	4.53e-05	0.000556	CcSEcCtD
Ticagrelor—Constipation—Docetaxel—lung cancer	4.51e-05	0.000554	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—lung cancer	4.5e-05	0.000553	CcSEcCtD
Ticagrelor—Pruritus—Etoposide—lung cancer	4.49e-05	0.000551	CcSEcCtD
Ticagrelor—Asthenia—Paclitaxel—lung cancer	4.46e-05	0.000548	CcSEcCtD
Ticagrelor—Nausea—Gemcitabine—lung cancer	4.41e-05	0.000542	CcSEcCtD
Ticagrelor—Vomiting—Cisplatin—lung cancer	4.4e-05	0.000541	CcSEcCtD
Ticagrelor—Pruritus—Paclitaxel—lung cancer	4.4e-05	0.00054	CcSEcCtD
Ticagrelor—Rash—Cisplatin—lung cancer	4.37e-05	0.000536	CcSEcCtD
Ticagrelor—Dermatitis—Cisplatin—lung cancer	4.36e-05	0.000536	CcSEcCtD
Ticagrelor—Feeling abnormal—Docetaxel—lung cancer	4.35e-05	0.000534	CcSEcCtD
Ticagrelor—Diarrhoea—Etoposide—lung cancer	4.34e-05	0.000533	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—lung cancer	4.33e-05	0.000532	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Docetaxel—lung cancer	4.31e-05	0.000529	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—lung cancer	4.3e-05	0.000528	CcSEcCtD
Ticagrelor—Diarrhoea—Paclitaxel—lung cancer	4.26e-05	0.000523	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—lung cancer	4.2e-05	0.000516	CcSEcCtD
Ticagrelor—Dizziness—Etoposide—lung cancer	4.2e-05	0.000515	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—lung cancer	4.18e-05	0.000514	CcSEcCtD
Ticagrelor—Vertigo—Methotrexate—lung cancer	4.18e-05	0.000514	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—lung cancer	4.17e-05	0.000513	CcSEcCtD
Ticagrelor—Abdominal pain—Docetaxel—lung cancer	4.17e-05	0.000512	CcSEcCtD
Ticagrelor—Body temperature increased—Docetaxel—lung cancer	4.17e-05	0.000512	CcSEcCtD
Ticagrelor—Dizziness—Paclitaxel—lung cancer	4.11e-05	0.000505	CcSEcCtD
Ticagrelor—Nausea—Cisplatin—lung cancer	4.11e-05	0.000505	CcSEcCtD
Ticagrelor—Cough—Methotrexate—lung cancer	4.06e-05	0.000499	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—lung cancer	4.06e-05	0.000498	CcSEcCtD
Ticagrelor—Vomiting—Etoposide—lung cancer	4.03e-05	0.000495	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—lung cancer	4.03e-05	0.000495	CcSEcCtD
Ticagrelor—Rash—Etoposide—lung cancer	4e-05	0.000491	CcSEcCtD
Ticagrelor—Dermatitis—Etoposide—lung cancer	4e-05	0.000491	CcSEcCtD
Ticagrelor—Headache—Etoposide—lung cancer	3.97e-05	0.000488	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—lung cancer	3.96e-05	0.000487	CcSEcCtD
Ticagrelor—Vomiting—Paclitaxel—lung cancer	3.96e-05	0.000486	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.94e-05	0.000483	CcSEcCtD
Ticagrelor—Rash—Paclitaxel—lung cancer	3.92e-05	0.000482	CcSEcCtD
Ticagrelor—Dermatitis—Paclitaxel—lung cancer	3.92e-05	0.000481	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—lung cancer	3.9e-05	0.000479	CcSEcCtD
Ticagrelor—Headache—Paclitaxel—lung cancer	3.9e-05	0.000479	CcSEcCtD
Ticagrelor—Hypersensitivity—Docetaxel—lung cancer	3.88e-05	0.000477	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—lung cancer	3.83e-05	0.000471	CcSEcCtD
Ticagrelor—Asthenia—Docetaxel—lung cancer	3.78e-05	0.000465	CcSEcCtD
Ticagrelor—Nausea—Etoposide—lung cancer	3.77e-05	0.000463	CcSEcCtD
Ticagrelor—Pruritus—Docetaxel—lung cancer	3.73e-05	0.000458	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—lung cancer	3.73e-05	0.000458	CcSEcCtD
Ticagrelor—Nausea—Paclitaxel—lung cancer	3.7e-05	0.000454	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—lung cancer	3.69e-05	0.000453	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—lung cancer	3.62e-05	0.000445	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—lung cancer	3.62e-05	0.000444	CcSEcCtD
Ticagrelor—Diarrhoea—Docetaxel—lung cancer	3.61e-05	0.000443	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—lung cancer	3.55e-05	0.000436	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—lung cancer	3.54e-05	0.000435	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—lung cancer	3.52e-05	0.000432	CcSEcCtD
Ticagrelor—Dizziness—Docetaxel—lung cancer	3.49e-05	0.000428	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—lung cancer	3.48e-05	0.000428	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—lung cancer	3.43e-05	0.000422	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—lung cancer	3.41e-05	0.000419	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.41e-05	0.000419	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—lung cancer	3.39e-05	0.000416	CcSEcCtD
Ticagrelor—Vomiting—Docetaxel—lung cancer	3.35e-05	0.000412	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—lung cancer	3.35e-05	0.000411	CcSEcCtD
Ticagrelor—Rash—Docetaxel—lung cancer	3.32e-05	0.000408	CcSEcCtD
Ticagrelor—Dermatitis—Docetaxel—lung cancer	3.32e-05	0.000408	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—lung cancer	3.32e-05	0.000407	CcSEcCtD
Ticagrelor—Headache—Docetaxel—lung cancer	3.3e-05	0.000406	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—lung cancer	3.28e-05	0.000403	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—lung cancer	3.28e-05	0.000402	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—lung cancer	3.24e-05	0.000398	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—lung cancer	3.23e-05	0.000396	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—lung cancer	3.2e-05	0.000393	CcSEcCtD
Ticagrelor—Nausea—Docetaxel—lung cancer	3.13e-05	0.000385	CcSEcCtD
Ticagrelor—Feeling abnormal—Methotrexate—lung cancer	3.13e-05	0.000385	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—lung cancer	3.11e-05	0.000382	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—lung cancer	3.07e-05	0.000378	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—lung cancer	3e-05	0.000369	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—lung cancer	3e-05	0.000369	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—lung cancer	2.95e-05	0.000363	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—lung cancer	2.93e-05	0.00036	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—lung cancer	2.9e-05	0.000356	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—lung cancer	2.84e-05	0.000349	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—lung cancer	2.84e-05	0.000348	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—lung cancer	2.81e-05	0.000346	CcSEcCtD
Ticagrelor—Hypersensitivity—Methotrexate—lung cancer	2.8e-05	0.000344	CcSEcCtD
Ticagrelor—Asthenia—Methotrexate—lung cancer	2.73e-05	0.000335	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—lung cancer	2.71e-05	0.000333	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—lung cancer	2.69e-05	0.00033	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—lung cancer	2.69e-05	0.00033	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—lung cancer	2.6e-05	0.000319	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—lung cancer	2.6e-05	0.000319	CcSEcCtD
Ticagrelor—Diarrhoea—Methotrexate—lung cancer	2.6e-05	0.000319	CcSEcCtD
Ticagrelor—Dizziness—Methotrexate—lung cancer	2.51e-05	0.000309	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—lung cancer	2.42e-05	0.000298	CcSEcCtD
Ticagrelor—Vomiting—Methotrexate—lung cancer	2.42e-05	0.000297	CcSEcCtD
Ticagrelor—Rash—Methotrexate—lung cancer	2.4e-05	0.000294	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—lung cancer	2.39e-05	0.000294	CcSEcCtD
Ticagrelor—Headache—Methotrexate—lung cancer	2.38e-05	0.000292	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—lung cancer	2.36e-05	0.00029	CcSEcCtD
Ticagrelor—CYP3A4—Biological oxidations—GCLC—lung cancer	2.34e-05	0.000918	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2A6—lung cancer	2.34e-05	0.000918	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	2.34e-05	0.000917	CbGpPWpGaD
Ticagrelor—Pruritus—Doxorubicin—lung cancer	2.33e-05	0.000286	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—ANXA1—lung cancer	2.32e-05	0.000911	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	2.28e-05	0.000893	CbGpPWpGaD
Ticagrelor—Nausea—Methotrexate—lung cancer	2.26e-05	0.000277	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—lung cancer	2.25e-05	0.000277	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—FLT1—lung cancer	2.25e-05	0.000882	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CG—lung cancer	2.23e-05	0.000874	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—EP300—lung cancer	2.23e-05	0.000873	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APP—lung cancer	2.2e-05	0.000863	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOTCH3—lung cancer	2.2e-05	0.000863	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGF9—lung cancer	2.18e-05	0.000856	CbGpPWpGaD
Ticagrelor—Dizziness—Doxorubicin—lung cancer	2.18e-05	0.000267	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—SRC—lung cancer	2.16e-05	0.000849	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—POMC—lung cancer	2.12e-05	0.000832	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—lung cancer	2.11e-05	0.000827	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	2.09e-05	0.000821	CbGpPWpGaD
Ticagrelor—Vomiting—Doxorubicin—lung cancer	2.09e-05	0.000257	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—JUNB—lung cancer	2.08e-05	0.000817	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NRAS—lung cancer	2.08e-05	0.000817	CbGpPWpGaD
Ticagrelor—Rash—Doxorubicin—lung cancer	2.07e-05	0.000255	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—lung cancer	2.07e-05	0.000255	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—lung cancer	2.06e-05	0.000253	CcSEcCtD
Ticagrelor—ABCB1—Metabolism—AZIN2—lung cancer	2.04e-05	0.0008	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—COL4A3BP—lung cancer	2.04e-05	0.0008	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—lung cancer	2.03e-05	0.000794	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CG—lung cancer	2.02e-05	0.000793	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.01e-05	0.000787	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MAPK3—lung cancer	1.99e-05	0.000782	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP2E1—lung cancer	1.99e-05	0.00078	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	1.96e-05	0.00077	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CD—lung cancer	1.96e-05	0.000768	CbGpPWpGaD
Ticagrelor—Nausea—Doxorubicin—lung cancer	1.95e-05	0.00024	CcSEcCtD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	1.93e-05	0.000755	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—POMC—lung cancer	1.93e-05	0.000755	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STK11—lung cancer	1.89e-05	0.000742	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6R—lung cancer	1.88e-05	0.000737	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FOXO3—lung cancer	1.83e-05	0.000716	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	1.81e-05	0.00071	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—KRAS—lung cancer	1.79e-05	0.000703	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAP2K1—lung cancer	1.79e-05	0.000702	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CD—lung cancer	1.78e-05	0.000697	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ATP5H—lung cancer	1.74e-05	0.000681	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AVP—lung cancer	1.71e-05	0.000671	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CB—lung cancer	1.71e-05	0.000669	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	1.67e-05	0.000655	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	1.65e-05	0.000648	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1R—lung cancer	1.65e-05	0.000646	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CA—lung cancer	1.65e-05	0.000646	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTP1—lung cancer	1.64e-05	0.000644	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	1.64e-05	0.000643	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL8—lung cancer	1.64e-05	0.000643	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HES1—lung cancer	1.62e-05	0.000635	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	1.62e-05	0.000635	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TP53—lung cancer	1.59e-05	0.000625	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—RAF1—lung cancer	1.59e-05	0.000623	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2—lung cancer	1.57e-05	0.000615	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	1.56e-05	0.00061	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CB—lung cancer	1.55e-05	0.000608	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	1.55e-05	0.000608	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLBD1—lung cancer	1.55e-05	0.000607	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—HRAS—lung cancer	1.52e-05	0.000597	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GSTM1—lung cancer	1.51e-05	0.000591	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	1.49e-05	0.000585	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL8—lung cancer	1.49e-05	0.000584	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	1.49e-05	0.000583	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB3—lung cancer	1.48e-05	0.00058	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	1.48e-05	0.00058	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	1.48e-05	0.000578	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	1.48e-05	0.000578	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.43e-05	0.000561	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL2—lung cancer	1.42e-05	0.000558	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TERT—lung cancer	1.42e-05	0.000556	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HSD17B10—lung cancer	1.41e-05	0.000555	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.41e-05	0.000553	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGFR1—lung cancer	1.38e-05	0.00054	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	1.37e-05	0.000538	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HIF1A—lung cancer	1.36e-05	0.000532	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT1—lung cancer	1.35e-05	0.000527	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.32e-05	0.000516	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CKB—lung cancer	1.32e-05	0.000516	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.31e-05	0.000514	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APOA1—lung cancer	1.31e-05	0.000513	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.3e-05	0.000509	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KDR—lung cancer	1.3e-05	0.000509	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.27e-05	0.000498	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.26e-05	0.000493	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AZIN2—lung cancer	1.26e-05	0.000493	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM2—lung cancer	1.24e-05	0.000485	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CNDP2—lung cancer	1.24e-05	0.000485	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTMR3—lung cancer	1.2e-05	0.000472	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KIT—lung cancer	1.2e-05	0.000469	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CG—lung cancer	1.2e-05	0.000469	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APC—lung cancer	1.2e-05	0.000469	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—NRAS—lung cancer	1.2e-05	0.000469	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGF—lung cancer	1.18e-05	0.000463	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.18e-05	0.000462	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PGAM1—lung cancer	1.17e-05	0.00046	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.15e-05	0.00045	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAPK3—lung cancer	1.14e-05	0.000449	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.14e-05	0.000449	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—POMC—lung cancer	1.14e-05	0.000446	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BRAF—lung cancer	1.12e-05	0.000441	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2A7—lung cancer	1.12e-05	0.000439	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6R—lung cancer	1.11e-05	0.000435	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.11e-05	0.000435	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CREBBP—lung cancer	1.11e-05	0.000435	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.11e-05	0.000434	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SDC4—lung cancer	1.09e-05	0.000429	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—lung cancer	1.09e-05	0.000427	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ATP5H—lung cancer	1.07e-05	0.000419	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—POMC—lung cancer	1.07e-05	0.000418	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAP2K1—lung cancer	1.06e-05	0.000415	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.06e-05	0.000414	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CD—lung cancer	1.05e-05	0.000412	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CA—lung cancer	1.04e-05	0.000408	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—KRAS—lung cancer	1.03e-05	0.000403	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.03e-05	0.000402	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1e-05	0.000392	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA3—lung cancer	9.97e-06	0.000391	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—RRM1—lung cancer	9.97e-06	0.000391	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLBD1—lung cancer	9.53e-06	0.000374	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	9.51e-06	0.000373	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	9.46e-06	0.000371	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CA—lung cancer	9.45e-06	0.000371	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MDM2—lung cancer	9.41e-06	0.000369	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RAF1—lung cancer	9.38e-06	0.000368	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—B4GALT5—lung cancer	9.37e-06	0.000368	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB2—lung cancer	9.28e-06	0.000364	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	9.2e-06	0.000361	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MTOR—lung cancer	9.16e-06	0.000359	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CB—lung cancer	9.16e-06	0.000359	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA4—lung cancer	9.12e-06	0.000358	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	9e-06	0.000353	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA2—lung cancer	8.89e-06	0.000348	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—lung cancer	8.8e-06	0.000345	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HRAS—lung cancer	8.74e-06	0.000343	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HSD17B10—lung cancer	8.72e-06	0.000342	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTA1—lung cancer	8.57e-06	0.000336	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—lung cancer	8.5e-06	0.000333	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	8.5e-06	0.000333	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCC3—lung cancer	8.48e-06	0.000332	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASP3—lung cancer	8.42e-06	0.00033	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2—lung cancer	8.41e-06	0.00033	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—lung cancer	8.37e-06	0.000328	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKR1C1—lung cancer	8.21e-06	0.000322	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCND1—lung cancer	8.2e-06	0.000321	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—JUN—lung cancer	8.18e-06	0.000321	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CKB—lung cancer	8.1e-06	0.000318	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UGT1A1—lung cancer	7.97e-06	0.000312	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—lung cancer	7.96e-06	0.000312	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1A—lung cancer	7.93e-06	0.000311	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTEN—lung cancer	7.91e-06	0.00031	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	7.81e-06	0.000306	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—lung cancer	7.72e-06	0.000303	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GNG11—lung cancer	7.68e-06	0.000301	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CNDP2—lung cancer	7.62e-06	0.000299	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM2—lung cancer	7.62e-06	0.000299	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	7.55e-06	0.000296	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EP300—lung cancer	7.55e-06	0.000296	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTMR3—lung cancer	7.41e-06	0.000291	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SRC—lung cancer	7.34e-06	0.000288	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALDOA—lung cancer	7.32e-06	0.000287	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	7.27e-06	0.000285	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PGAM1—lung cancer	7.22e-06	0.000283	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—lung cancer	7.15e-06	0.00028	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NCOA3—lung cancer	7.1e-06	0.000279	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—lung cancer	7.08e-06	0.000278	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NRAS—lung cancer	7.06e-06	0.000277	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCG2—lung cancer	6.91e-06	0.000271	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ADCY1—lung cancer	6.91e-06	0.000271	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2A7—lung cancer	6.89e-06	0.00027	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ENO2—lung cancer	6.78e-06	0.000266	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HPGDS—lung cancer	6.78e-06	0.000266	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK3—lung cancer	6.76e-06	0.000265	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SDC4—lung cancer	6.74e-06	0.000264	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPP2R1B—lung cancer	6.73e-06	0.000264	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MYC—lung cancer	6.58e-06	0.000258	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTT1—lung cancer	6.57e-06	0.000258	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GCLC—lung cancer	6.5e-06	0.000255	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2A6—lung cancer	6.5e-06	0.000255	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—lung cancer	6.43e-06	0.000252	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	6.38e-06	0.00025	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ENO1—lung cancer	6.16e-06	0.000241	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.15e-06	0.000241	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—RRM1—lung cancer	6.14e-06	0.000241	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA3—lung cancer	6.14e-06	0.000241	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KRAS—lung cancer	6.08e-06	0.000238	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—B4GALT5—lung cancer	5.77e-06	0.000226	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.76e-06	0.000226	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA4—lung cancer	5.62e-06	0.00022	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CA—lung cancer	5.58e-06	0.000219	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP2E1—lung cancer	5.52e-06	0.000217	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA2—lung cancer	5.47e-06	0.000215	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NQO1—lung cancer	5.46e-06	0.000214	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TP53—lung cancer	5.4e-06	0.000212	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTA1—lung cancer	5.28e-06	0.000207	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCC3—lung cancer	5.22e-06	0.000205	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.21e-06	0.000204	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HRAS—lung cancer	5.17e-06	0.000203	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKR1C1—lung cancer	5.06e-06	0.000198	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—lung cancer	4.94e-06	0.000194	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—STK11—lung cancer	4.92e-06	0.000193	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UGT1A1—lung cancer	4.91e-06	0.000193	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GNG11—lung cancer	4.73e-06	0.000186	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—lung cancer	4.56e-06	0.000179	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTP1—lung cancer	4.56e-06	0.000179	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALDOA—lung cancer	4.51e-06	0.000177	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAT—lung cancer	4.43e-06	0.000174	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NCOA3—lung cancer	4.38e-06	0.000172	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ADCY1—lung cancer	4.26e-06	0.000167	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCG2—lung cancer	4.26e-06	0.000167	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—TYMS—lung cancer	4.24e-06	0.000166	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GSTM1—lung cancer	4.19e-06	0.000164	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ENO2—lung cancer	4.17e-06	0.000164	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HPGDS—lung cancer	4.17e-06	0.000164	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.15e-06	0.000163	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTT1—lung cancer	4.05e-06	0.000159	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GCLC—lung cancer	4e-06	0.000157	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2A6—lung cancer	4e-06	0.000157	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1A1—lung cancer	3.97e-06	0.000156	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ERCC2—lung cancer	3.94e-06	0.000154	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ENO1—lung cancer	3.79e-06	0.000149	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—APOA1—lung cancer	3.41e-06	0.000134	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP2E1—lung cancer	3.4e-06	0.000133	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NQO1—lung cancer	3.37e-06	0.000132	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CG—lung cancer	3.11e-06	0.000122	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—STK11—lung cancer	3.03e-06	0.000119	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—POMC—lung cancer	2.96e-06	0.000116	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CREBBP—lung cancer	2.88e-06	0.000113	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTP1—lung cancer	2.81e-06	0.00011	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CD—lung cancer	2.73e-06	0.000107	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAT—lung cancer	2.73e-06	0.000107	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—lung cancer	2.7e-06	0.000106	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCB1—lung cancer	2.66e-06	0.000104	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—TYMS—lung cancer	2.61e-06	0.000102	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GSTM1—lung cancer	2.58e-06	0.000101	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1A1—lung cancer	2.45e-06	9.59e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ERCC2—lung cancer	2.43e-06	9.51e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CB—lung cancer	2.38e-06	9.34e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—lung cancer	2.36e-06	9.25e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—APOA1—lung cancer	2.1e-06	8.23e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTEN—lung cancer	2.06e-06	8.07e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—EP300—lung cancer	1.96e-06	7.7e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CG—lung cancer	1.92e-06	7.51e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—POMC—lung cancer	1.82e-06	7.15e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CREBBP—lung cancer	1.78e-06	6.96e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CD—lung cancer	1.68e-06	6.6e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—lung cancer	1.66e-06	6.52e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CB—lung cancer	1.47e-06	5.75e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—lung cancer	1.45e-06	5.7e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CA—lung cancer	1.45e-06	5.69e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTEN—lung cancer	1.27e-06	4.97e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—EP300—lung cancer	1.21e-06	4.74e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—lung cancer	1.19e-06	4.65e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CA—lung cancer	8.95e-07	3.51e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—lung cancer	7.31e-07	2.87e-05	CbGpPWpGaD
